Australia offers financial aid to early phase clinical trials in APAC
Singapore, April 10 -- Leading Australian CRO Avance Clinical on 3 April 2020 detailed the top reasons it's APAC biotechs selected Australia for their early phase clinical trials, based on client onboarding feedback.
Avance Clinical is a specialist Australian CRO with more than 20-years of early phase clinical trials expertise.
Avance Clinical said a primary reason that APAC biotechs chose Australia was the attractive Australian Government financial rebate of more than 40% on clinical trial spend.
Avance Clinical CEO Yvonne Lungershausen said this makes good financial sense for biotechs in early clinical phases.
Another key factor is that, during the current COVID-19 pandemic, sites can pivot to patient video visits or telemedicine, w...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.